Literature DB >> 17006695

Direct stimulatory effects of the TLR2/6 ligand bacterial lipopeptide MALP-2 on neutrophil granulocytes.

Inga Wilde1, Sonja Lotz, David Engelmann, Andrea Starke, Ger van Zandbergen, Werner Solbach, Tamás Laskay.   

Abstract

Bacterial lipopeptides represent a group of bacterial compounds able to trigger the functions of cells of the innate immune response. Whereas diacylated lipopeptides are recognized by TLR2/6 dimers, triacylated lipopeptides were shown to act via TLR2/1 dimers. Although several previous studies dealt with the effect of the TLR2/1 ligand Pam(3)CysSK(4) on neutrophil granulocytes (PMN), it is still not clear whether TLR2/6 ligand lipopeptides can directly influence PMN functions. In the present study we used highly purified human neutrophils to investigate the direct effects of the diacylated mycoplasmal macrophage activating lipopeptide-2 (MALP-2) on the function of neutrophil granulocytes. After exposure to 10 ng/ml MALP-2 neutrophils acquired activated cell shape, secreted IL-8 and MIP-1beta and their phagocytic capacity was enhanced. Analysis of cell surface activation markers confirmed the activating effect of MALP-2, the expression of CD62L was downregulated whereas CD11b was upregulated on PMN after exposure to MALP-2. The constitutive apoptosis of PMN was inhibited after exposure to MALP-2. However, MALP-2 exerted only a short-term effect on the apoptosis of resting neutrophils, a longer lasting effect was observed after transendothelial migration. MALP-2 did not directly induce the production of reactive oxygen intermediates but primed PMN for a fMLP-induced oxidative burst. The migration of neutrophils was enhanced after treatment with MALP-2. This was due, however, to a chemokinetic rather than to a chemotactic effect. Pam(3)CysSK(4) also activated PMN, but in comparison to MALP-2, at higher concentrations. These findings suggest that diacylated lipopeptides are important microbial structures recognized by and acting on neutrophil granulocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006695     DOI: 10.1007/s00430-006-0027-9

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  47 in total

1.  Bacterial lipoprotein delays apoptosis in human neutrophils through inhibition of caspase-3 activity: regulatory roles for CD14 and TLR-2.

Authors:  Colm P Power; Jiang H Wang; Brian Manning; Malcolm R Kell; Noel J Aherne; Noel F Aherne; Qiong D Wu; H Paul Redmond
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

2.  Mycobacterium tuberculosis 19-kDa lipoprotein promotes neutrophil activation.

Authors:  C Neufert; R K Pai; E H Noss; M Berger; W H Boom; C V Harding
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

3.  Intracellular survival of Leishmania major in neutrophil granulocytes after uptake in the absence of heat-labile serum factors.

Authors:  Helmut Laufs; Kerstin Müller; Jens Fleischer; Norbert Reiling; Nicole Jahnke; Jens C Jensenius; Werner Solbach; Tamás Laskay
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  Neutrophil activation by bacterial lipoprotein versus lipopolysaccharide: differential requirements for serum and CD14.

Authors:  A M Soler-Rodriguez; H Zhang; H S Lichenstein; N Qureshi; D W Niesel; S E Crowe; J W Peterson; G R Klimpel
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

5.  Neutrophils secrete MIP-1 beta after adhesion to laminin contained in basement membrane of blood vessels.

Authors:  Kouji Chiba; Wenli Zhao; Jiang Chen; Jingxin Wang; Hong Yan Cui; Hiroshi Kawakami; Tetsuya Miseki; Hashino Satoshi; Junji Tanaka; Masahiro Asaka; Masanobu Kobayashi
Journal:  Br J Haematol       Date:  2004-12       Impact factor: 6.998

6.  Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides.

Authors:  R Seifert; G Schultz; M Richter-Freund; J Metzger; K H Wiesmüller; G Jung; W G Bessler; S Hauschildt
Journal:  Biochem J       Date:  1990-05-01       Impact factor: 3.857

Review 7.  Neutrophil priming in host defense: role of oxidants as priming agents.

Authors:  Steve D Swain; Troy T Rohn; Mark T Quinn
Journal:  Antioxid Redox Signal       Date:  2002-02       Impact factor: 8.401

8.  Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells.

Authors:  Jeffrey D McCurdy; Timothy J Olynych; Lauren H Maher; Jean S Marshall
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

9.  Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.

Authors:  F Colotta; F Re; N Polentarutti; S Sozzani; A Mantovani
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

10.  Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses.

Authors:  Nicolas W J Schröder; Holger Heine; Christian Alexander; Maria Manukyan; Jana Eckert; Lutz Hamann; Ulf B Göbel; Ralf R Schumann
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

View more
  9 in total

1.  A Common Genetic Variant in TLR1 Enhances Human Neutrophil Priming and Impacts Length of Intensive Care Stay in Pediatric Sepsis.

Authors:  Laura C Whitmore; Jessica S Hook; Amanda R Philiph; Brieanna M Hilkin; Xinyu Bing; Chul Ahn; Hector R Wong; Polly J Ferguson; Jessica G Moreland
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.422

2.  Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.

Authors:  Katrin Reppe; Peter Radünzel; Kristina Dietert; Thomas Tschernig; Thorsten Wolff; Sven Hammerschmidt; Achim D Gruber; Norbert Suttorp; Martin Witzenrath
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

3.  Co-upregulation of Toll-like receptors 2 and 6 on peripheral blood cells in patients with obstructive sleep apnea.

Authors:  Yung-Che Chen; Mao-Chang Su; Chia-Wei Liou; Shih-Feng Liu; Chung-Jen Chen; Hsin-Ching Lin; Chang-Chun Hsiao; Ting-Ya Wang; Chin-Chou Wang; Chien-Hung Chin; Kuo-Tung Huang; An-Shen Lin; Meng-Chih Lin
Journal:  Sleep Breath       Date:  2015-01-22       Impact factor: 2.816

4.  TLR2/6 stimulation of the rat lung: effects on lymphocyte subsets, natural killer cells and dendritic cells in different parts of the air-conducting compartments and at different ages.

Authors:  Reinhard Pabst; Deniz Durak; Anna Roos; Anke Lührmann; Thomas Tschernig
Journal:  Immunology       Date:  2008-06-19       Impact factor: 7.397

5.  Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells.

Authors:  Matthew R Kimbrell; Hemamali Warshakoon; Jens R Cromer; Subbalakshmi Malladi; Jennifer D Hood; Rajalakshmi Balakrishna; Tandace A Scholdberg; Sunil A David
Journal:  Immunol Lett       Date:  2008-04-18       Impact factor: 3.685

6.  Cellular Microbiology of Mycoplasma canis.

Authors:  Dina L Michaels; Jeffrey A Leibowitz; Mohammed T Azaiza; Pollob K Shil; Suzanne M Shama; Gerald F Kutish; Steven L Distelhorst; Mitchell F Balish; Meghan A May; Daniel R Brown
Journal:  Infect Immun       Date:  2016-05-24       Impact factor: 3.441

7.  Proinflammatory stimuli enhance phagocytosis of apoptotic cells by neutrophil granulocytes.

Authors:  Lars Hellberg; Sabrina Fuchs; Christoph Gericke; Arup Sarkar; Martina Behnen; Werner Solbach; Tamás Laskay
Journal:  ScientificWorldJournal       Date:  2011-11-15

8.  Human filarial Wolbachia lipopeptide directly activates human neutrophils in vitro.

Authors:  F Tamarozzi; H L Wright; K L Johnston; S W Edwards; J D Turner; M J Taylor
Journal:  Parasite Immunol       Date:  2014-10       Impact factor: 2.280

9.  Modulation of asthma and allergy by addressing toll-like receptor 2.

Authors:  Barbara Fuchs; Armin Braun
Journal:  J Occup Med Toxicol       Date:  2008-02-27       Impact factor: 2.646

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.